查看完整行情页>>
|
货币单位:美元(USD)
OncoMed Pharmaceuticals, Inc. (omed)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| BlackRock Fund Advisors |
67492 |
0.17% |
6 |
0.01% |
2019-03-31
|
| Vanguard Group Inc |
355294 |
0.92% |
-656062 |
-64.87% |
2018-12-31
|
| Candriam Belgium |
380000 |
0.98% |
-- |
-- |
2019-03-31
|
| Candriam Luxembourg |
380000 |
0.98% |
-- |
-- |
2018-12-31
|
| Renaissance Technologies Corp |
1218607 |
3.15% |
401207 |
49.08% |
2018-12-31
|
| Perceptive Advisors LLC |
1719111 |
4.44% |
-901786 |
-34.41% |
2018-12-31
|
| Harbourvest Partners, LLC |
1901106 |
4.91% |
1901106 |
-- |
2018-12-31
|
| Bvf Inc |
4042989 |
10.45% |
-- |
-- |
2018-12-31
|
| PRIMECAP Management Company |
5506300 |
14.23% |
-192400 |
-3.38% |
2018-12-31
|
| Geode Capital Management, LLC |
347126 |
0.90% |
219646 |
172.30% |
2018-12-31
|
| Cannell Peter B & CO Inc |
303071 |
0.78% |
-- |
-- |
2018-12-31
|
| BlackRock Inc |
227637 |
0.59% |
-13566 |
-5.62% |
2018-12-31
|
| Bank of America Corporation |
83826 |
0.22% |
-- |
-- |
2018-12-31
|
| Dimensional Fund Advisors, Inc. |
85741 |
0.22% |
-8500 |
-9.02% |
2018-12-31
|
| Spark Investment Management LLC |
91400 |
0.24% |
-4300 |
-4.49% |
2018-12-31
|
| Bridgeway Capital Management, Inc |
130900 |
0.34% |
-- |
-- |
2018-12-31
|
| D. E. Shaw & Co LP |
156249 |
0.40% |
-171920 |
-52.39% |
2018-12-31
|
| Jacobs Levy Equity Management, Inc. |
160244 |
0.41% |
75514 |
89.12% |
2018-12-31
|
| Birchview Capital, LP |
172557 |
0.45% |
53868 |
45.39% |
2018-12-31
|
| Fidelity Management & Research Company |
196375 |
0.51% |
24292 |
14.12% |
2019-03-31
|
| NEXTHERA CAPITAL LP |
634715 |
1.64% |
634715 |
-- |
2018-09-30
|
| Sofinnova Ventures |
395744 |
1.02% |
-69399 |
-14.92% |
2018-09-30
|
| Endurant Capital Management LP |
219114 |
0.57% |
219114 |
-- |
2018-09-30
|
| Broadfin Capital, LLC |
200000 |
0.52% |
200000 |
-- |
2018-09-30
|
| Acadian Asset Management LLC |
154754 |
0.40% |
154754 |
-- |
2018-09-30
|
| Vanguard Investments Australia Ltd |
603265 |
1.56% |
-- |
-- |
2018-12-31
|
| BlackRock Institutional Trust Company NA |
163885 |
0.42% |
-- |
-- |
2018-06-30
|
| Crestline Management LP |
209088 |
0.54% |
8134 |
4.05% |
2018-06-30
|
| Columbia Mgmt Investment Advisers, LLC |
282925 |
0.73% |
-21100 |
-6.94% |
2018-06-30
|
| Ameriprise Financial Inc |
283220 |
0.73% |
-21100 |
-6.93% |
2018-06-30
|
| Alyeska Investment Group, L.P. |
534309 |
1.38% |
17086 |
3.30% |
2018-06-30
|
| Iguana Healthcare Management, LLC |
150000 |
0.39% |
-- |
-- |
2018-03-31
|
| Disciplined Growth Investors Inc |
151879 |
0.39% |
-157338 |
-50.88% |
2018-06-30
|
| Millennium Management LLC |
232774 |
0.60% |
-310561 |
-57.16% |
2018-03-31
|
| Alambic Investment Management, L.P. |
109885 |
0.29% |
109885 |
-- |
2018-06-30
|
| AXA Investment Managers UK Limited |
108300 |
0.28% |
-- |
-- |
2018-05-31
|
| Arnhold & S. Bleichroeder Advisers, LLC |
219420 |
0.57% |
-- |
-- |
2018-06-30
|
| Columbia Mangmt Investment Advisers, LLC |
282925 |
0.74% |
-21100 |
-6.94% |
2018-06-30
|
| Columbia Management Company |
145475 |
0.38% |
-- |
-- |
2018-03-31
|
| AllianceBernstein LP |
131785 |
0.34% |
-- |
-- |
2018-03-31
|
| NORGES BANK |
182357 |
0.48% |
-- |
-- |
2017-12-31
|
| Adams Street Partners LLC |
490707 |
1.28% |
-982354 |
-66.69% |
2017-12-31
|
| Vertical Group Lp |
1119905 |
3.02% |
-790122 |
-41.37% |
2017-01-10
|
| US VENTURE PARTNERS VIII LP |
2133356 |
5.75% |
2133356 |
-- |
2016-12-31
|
| Goldman, Sachs & Co. |
170439 |
0.45% |
-155991 |
-47.79% |
2017-06-30
|
| Morgenthaler Management Partners VII, LLC |
2509672 |
8.33% |
-- |
-- |
2015-12-31
|
| Presidio Management Group VIII, L.L.C. |
2038272 |
6.77% |
-- |
-- |
2015-12-31
|
| Celgene Corp |
2970588 |
9.69% |
1500000 |
102.00% |
2016-08-23
|
| Franklin Advisers Inc |
993900 |
2.68% |
700000 |
238.18% |
2016-09-30
|
| Fidelity Management and Research Company |
911303 |
2.46% |
-- |
-- |
2016-09-30
|
| State Street Corp |
295100 |
0.80% |
30261 |
11.43% |
2016-09-30
|
| Northern Trust Investments N A |
256933 |
0.69% |
33587 |
15.04% |
2016-09-30
|
| EcoR1 Capital, LLC |
265784 |
0.72% |
265784 |
-- |
2016-09-30
|
| Morgenthaler Partners VII, L.P. |
2509672 |
4.00% |
68488949 |
0.10% |
1999-11-30
|
| Entities Affiliated with Latterell Venture Partners |
2470554 |
4.00% |
67421419 |
0.10% |
1999-11-30
|
| Jack W. Lasersohn, J.D. |
2343202 |
4.00% |
63945983 |
0.10% |
1999-11-30
|
| Jonathan D. Root, M.D. |
2038272 |
4.00% |
55624443 |
0.10% |
1999-11-30
|
| Deepa R. Pakianathan, Ph.D. |
2010542 |
4.00% |
54867691 |
0.10% |
1999-11-30
|
| GlaxoSmithKline LLC |
2607546 |
4.00% |
71159930 |
0.10% |
1999-11-30
|
| Elisha P. (?°Terry?±) Gould III |
1663650 |
4.00% |
45401008 |
0.10% |
1999-11-30
|
| Sectoral Asset Management Inc. |
1598293 |
4.00% |
43617416 |
-- |
1999-11-30
|
| Denise Pollard-Knight, Ph.D. |
1943509 |
4.00% |
53038361 |
0.10% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Vanguard Instl Total Stock Market Idx Fd |
31662 |
0.08% |
-- |
-- |
2019-02-28
|
| BNYM Mellon SL Mkt Completion Fd |
1164 |
-- |
-4400 |
-79.08% |
2018-12-31
|
| PrimeCap Odyssey Aggressive Growth Fund |
3786300 |
9.79% |
-44298 |
-1.16% |
2018-12-31
|
| Vanguard US Opportunities Fund |
1720000 |
4.45% |
-95600 |
-5.27% |
2018-12-31
|
| Candriam Eqs L Biotechnology |
380000 |
0.98% |
-- |
-- |
2019-02-28
|
| Vanguard Extended Market Index Fund |
287555 |
0.74% |
-- |
-- |
2019-02-28
|
| Bridgeway Ultra Small Company Market Fd |
125000 |
0.32% |
-- |
-- |
2018-12-31
|
| Schwab US Small-Cap ETF |
69629 |
0.18% |
-- |
-- |
2018-09-21
|
| iShares Micro-Cap ETF |
60904 |
0.16% |
-- |
-- |
2019-03-29
|
| BlackRock Extended Equity Market |
27999 |
0.07% |
126 |
0.45% |
2019-03-31
|
| The Vanguard Total Stock Market Index |
6032 |
0.02% |
-- |
-- |
2019-02-28
|
| 1290 VT Micro Cap Portfolio |
4471 |
0.01% |
-- |
-- |
2019-01-31
|
| USAA Extended Market Index Fund |
3414 |
0.01% |
-- |
-- |
2019-02-28
|
| Vanguard US Equity Index Fund |
6355 |
0.02% |
-- |
-- |
2019-02-28
|
| iShares Core S&P Total US Stock Mkt ETF |
6588 |
0.02% |
6 |
0.09% |
2019-03-29
|
| State Street U.S. Extended Market Index |
9789 |
0.03% |
-- |
-- |
2019-02-28
|
| Vanguard Balanced Index Fund |
23558 |
0.06% |
-- |
-- |
2019-02-28
|
| Fidelity |
27577 |
0.07% |
-- |
-- |
2019-02-28
|
| Blackstone Alternative Multi-Strategy Fd |
700 |
-- |
-- |
-- |
2018-12-31
|
| BNY Mellon Market Completion Fund |
1164 |
-- |
-4400 |
-79.08% |
2018-12-31
|
| CC&L Q Equity Extension |
700 |
-- |
-- |
-- |
2018-11-30
|
| DFA US Core Equity II Fund |
45326 |
0.12% |
-- |
-- |
2018-12-31
|
| DFA US Core Equity 1 Portfolio |
30649 |
0.08% |
-- |
-- |
2018-12-31
|
| DFA T.A. US Core Equity 2 Portfolio |
5400 |
0.01% |
-- |
-- |
2018-12-31
|
| DFA US Vector Equity Fund |
4366 |
0.01% |
-- |
-- |
2018-12-31
|
| Dimensional World Equity Fund |
4600 |
0.01% |
-- |
-- |
2018-09-30
|
| Invesco Wilshire Micro-Cap ETF |
5115 |
0.01% |
-- |
-- |
2019-01-31
|
| Wells Fargo Factor Enhanced Sm Cp IdxCIT |
9591 |
0.02% |
-- |
-- |
2018-09-30
|
| Wells Fargo Factor Enhanced Small Cap |
6822 |
0.02% |
-- |
-- |
2018-11-30
|
| Zacks Market Neutral Fund |
21597 |
0.06% |
-- |
-- |
2018-08-31
|
| Vanguard Total Stock Market Index Fund |
608160 |
1.57% |
-- |
-- |
2018-11-30
|
| AXA Rosenberg Global Small Cap Alpha Fd |
10900 |
0.03% |
-71800 |
-86.82% |
2018-10-31
|
| Columbia VP US Equities Fund |
204200 |
0.53% |
-1900 |
-0.92% |
2018-08-31
|
| Vanguard Health Care Index Fund |
48782 |
0.13% |
748 |
1.56% |
2018-10-31
|
| Columbia Disciplined Small Core Fund |
43400 |
0.11% |
-1800 |
-3.98% |
2018-08-31
|
| Columbia VP Small Cap Value Fund |
56362 |
0.15% |
-64975 |
-53.55% |
2018-01-31
|
| Columbia Small Cap Growth Fund I |
38266 |
0.10% |
-193934 |
-83.52% |
2018-01-31
|
| Columbia Small Cap Value Fund I |
95563 |
0.25% |
-109271 |
-53.35% |
2018-01-31
|
| iShares Nasdaq Biotechnology ETF |
573882 |
1.49% |
920 |
0.16% |
2017-11-30
|
| Bridgeway Ultra-Small Company Market |
125000 |
0.33% |
50000 |
66.67% |
2018-06-30
|
| Vanguard Balanced Index Inv |
16658 |
0.04% |
-- |
-- |
2018-07-31
|
| BNY Mellon EB DL Mkt Completion |
17287 |
0.04% |
-- |
-- |
2018-06-30
|
| DFA US Core Equity 1 I |
20341 |
0.05% |
20341 |
-- |
2018-07-31
|
| DFA US Core Equity 2 I |
24263 |
0.06% |
24263 |
-- |
2018-07-31
|
| SPDR |
18171 |
0.06% |
57 |
0.31% |
2018-09-13
|
| Vanguard Total Stock Mkt Idx |
603265 |
1.57% |
-- |
-- |
2018-07-31
|
| Vanguard Extended Market Idx Inv |
287555 |
0.75% |
-- |
-- |
2018-07-31
|
| Columbia VP US Equities 2 |
206100 |
0.54% |
-- |
-- |
2018-07-31
|
| iShares Micro-Cap |
67270 |
0.21% |
-- |
-- |
2018-09-12
|
| Vanguard Health Care ETF |
45614 |
0.12% |
396 |
0.88% |
2018-07-31
|
| Columbia Small Cap Core Z |
45200 |
0.12% |
-- |
-- |
2018-07-31
|
| Vanguard Instl Ttl Stk Mkt Idx InstlPls |
36557 |
0.10% |
-- |
-- |
2018-07-31
|
| Securian DGI Small Cap Growth SP 1 |
22655 |
0.08% |
-4445 |
-16.40% |
2018-06-30
|
| Zacks Market Neutral A |
21597 |
0.06% |
-- |
-- |
2018-05-31
|
| BlackRock Extended Equity Market K |
27771 |
0.07% |
755 |
2.79% |
2018-06-30
|
| Fidelity Spartan |
27577 |
0.07% |
-- |
-- |
2018-07-31
|
| PRIMECAP Odyssey Aggressive Growth |
3763700 |
9.79% |
-- |
-- |
2018-06-30
|
| Columbia Capital Allocation Mod Agrsv A |
9100 |
0.02% |
-- |
-- |
2018-07-31
|
| Columbia Small Cap Growth I Z |
38266 |
0.10% |
-193934 |
-83.52% |
2018-01-31
|
| Columbia VP Small Cap Value 2 |
56362 |
0.15% |
-64975 |
-53.55% |
2018-01-31
|
| Columbia Small Cap Value Fund I A |
95563 |
0.25% |
-109271 |
-53.35% |
2018-01-31
|
| Columbia VP Small Company Growth 2 |
15316 |
0.04% |
-- |
-- |
2017-12-31
|
| BNY Mellon Market Completion Fund UC1 |
17287 |
0.05% |
16224 |
1526.25% |
2017-09-30
|
| ProShares Ultra Nasdaq Biotechnology |
21716 |
0.06% |
931 |
4.48% |
2017-11-30
|
| iShares Russell 2000 Growth |
176924 |
0.46% |
-- |
-- |
2017-02-07
|
| Eventide Healthcare & Life Sciences A |
190000 |
0.51% |
-- |
-- |
2016-09-30
|
| Franklin Biotechnology Discovery A |
376800 |
1.02% |
-- |
-- |
2016-12-31
|
| iShares Nasdaq Biotechnology |
520726 |
1.35% |
-1808 |
-0.35% |
2017-02-07
|
| Schwab Small Cap Index |
36500 |
0.10% |
-- |
-- |
2016-12-31
|
| Fidelity Advisor |
154870 |
0.42% |
-- |
-- |
2016-12-31
|
| ALPS Medical Breakthroughs ETF |
34005 |
0.09% |
-1640 |
-4.60% |
2017-01-31
|
| QS Batterymarch US Sm Cap Eq I |
49793 |
0.13% |
-- |
-- |
2016-12-31
|
| AXA 2000 Managed Volatility K |
33976 |
0.09% |
-- |
-- |
2016-11-30
|
| Turner Titan Long/Short Institutional |
38083 |
0.10% |
-- |
-- |
2016-12-31
|
| CREF Stock R1 |
45988 |
0.12% |
-- |
-- |
2016-12-31
|
| Northern Trust Russell 2000 Index Fund - DC - Non-Lending |
49017 |
0.13% |
4088 |
9.10% |
2016-12-31
|
| Fidelity® Select Biotechnology Portfolio |
764832 |
2.50% |
-- |
-- |
2015-09-30
|
| iShares Russell 2000 (AU) |
270628 |
1.00% |
-342 |
-0.10% |
2015-11-19
|
| Wells Fargo Advantage Small Co Growth |
201042 |
0.70% |
19407 |
10.70% |
2015-09-30
|
| Franklin Biotechnology Discovery |
157600 |
0.50% |
-- |
-- |
2015-07-31
|
| Pictet-Biotech |
1098155 |
3.80% |
-147230 |
-11.80% |
2014-09-30
|
| Fidelity Advisor® Biotechnology Fund |
128832 |
0.40% |
-- |
-- |
2015-09-30
|
| Franklin Biotechnology Discovery Fund |
110900 |
0.40% |
19200 |
20.90% |
2015-09-30
|
| IronBridge Small Cap Fund |
106200 |
0.40% |
20940 |
24.60% |
2015-09-30
|
| Thrivent Partner Healthcare |
91258 |
0.30% |
26030 |
39.90% |
2015-08-31
|
| Pictet-Global Megatrend Selection |
147230 |
0.50% |
267 |
0.20% |
2014-09-30
|
